Table 1 Epidemiological and surgical data from patients with postoperative low cardiac output syndrome
Inotropic therapy | ||||
|---|---|---|---|---|
Beta-agonists (n = 50) | Levosimendan(n = 50) | |||
% | Mean ± SD | Mean ± SD | % | |
Sex | ||||
Female | 25.0% | 42.9%(p > 0.05) | ||
Male | 75.0% | 57.1%(p > 0.05) | ||
Total | 100.0% | 100.0% | ||
Age | ||||
Height | 166.9 ± 7.8 | 165.5 ± 8.9 | (p > 0.05) | |
Weight | 76.5 ± 14.2 | 76.9 ± 13.8 | (p > 0.05) | |
BMI - Category | ||||
BMI – Category | ||||
Underweight | 0.0% | 0.0%(p > 0.05) | ||
Healthy weight | 38.5% | 22.2%(p > 0.05) | ||
Overweight | 38.5% | 55.6%(p > 0.05) | ||
Obesity | 19.2% | 22.2%(p > 0.05) | ||
Morbid obesity | 3.8% | 0.0%(p > 0.05) | ||
Total | 100.0% | 100.0% | ||
EuroScore II (%) | 2.7 ± 3. 3 | 3.2 ± 2.6 | (p > 0.05) | |
NYHA | ||||
II | 46.2% | 28.6%(p > 0.05) | ||
III | 28.8% | 42.9%(p > 0.05) | ||
IV | 7.7% | 10.7%(p > 0.05) | ||
Total | 100.0% | 100.0% | ||
Type of surgery | ||||
Valve surgery | 43.1% | 33.3%(p > 0.05) | ||
Coronary artery bypass with ECC | 2.0% | 7.4%(p > 0.05) | ||
Coronary artery bypass without ECC | 23.5% | 40.7%(p > 0.05) | ||
Combined | 27.5% | 18.5%(p > 0.05) | ||
Ascending thoracic aortic | 3.9% | 0.0% | ||
Total | 100.0% | 100.0% | ||
Beta-blockers | ||||
No | 41.7% | 30.0%(p > 0.05) | ||
Yes | 58.3% | 70.0%(p > 0.05) | ||
Total | 100.0% | 100.0%(p > 0.05) | ||
ACEs | ||||
No | 55.6% | 60.0%(p > 0.05) | ||
Yes | 44.4% | 40.0%(p > 0.05) | ||
Total | 100.0% | 100.0%(p > 0.05) | ||
ARBs II | ||||
No | 63.9% | 75.0%(p > 0.05) | ||
Yes | 36.1% | 25.0%(p > 0.05) | ||
Total | 100.0% | 100.0%(p > 0.05) | ||
Clamping ischemia (minutes) | 72.9 ± | 67.67 ± | (p > 0.05) | |
Therapy for dyslipidemia | ||||
No | 7.7% | 31.31 | 37.9 | 6.3%(p > 0.05) |
Yes | 92.3% | 93.8%(p > 0.05) | ||
Total | 100.0% | 100.0% | ||